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Abstract: Background: To assess differences in marginal bone loss in implants placed at subcrestal
versus crestal level. Methods: An electronic and a manual research of articles written in English from
Jaunary 2010 to January 2018 was performed by two independent reviewers. Clinical trials comparing
bone loss for implants placed at crestal and subcrestal level were included. Pooled estimates from
comparable studies were analyzed using a continuous random-effects model meta-analysis with the
objective of assessing differences in crestal bone loss between the two vertical positions. Results:
16 studies were included; 10 studies did not encounter statistically significant differences between the
two groups with respect to bone loss. Three articles found greater bone loss in subcrestal implants;
while 3 found more bone loss in crestal implants. A meta-analysis for randomized control trial
(RCT) studies reported an average and non-statistically different crestal bone loss of 0.028 mm.
Conclusions: A high survival rate and a comparable bone loss was obtained both for crestal and
subcrestal implants’ placement. Quantitative analysis considering a homogenous sample confirms
that both vertical positions are equally valid in terms of perimplant bone loss. However, with respect
to soft tissue; in presence of a thin tissue; a subcrestal placement of the implant should be preferred
as it may reduce the probability for the implant to become exposed in the future and thus avoid the
risk of suffering from peri-implant pathologies.
Keywords: systematic review; subcrestal; crestal; bone loss; implants; meta-analysis
1. Introduction
Dental implants have become the preferred choice for the replacement of missing teeth.
The five-year success rate of dental implants has increased from 93.5% to 97.1% within the past decade,
with a higher survival and a lower complication rate [1]. Patients increasingly require treatments
that offer more aesthetics and comfort, making implantology a demanding field, where, obtaining
osseointegration or meeting the success criteria of implants highlighted by Buser et al. in the 1990s [2],
such as lack of pain and infection, absence of radiolucency and mobility and possibility of restoration,
is no longer considered a sufficient condition.
Research in the area of implantology has been evolving substantively. Scientists begin to devote
their attention to physical and chemical properties of the implants; on creating different types of
surfaces and degrees of roughness [3,4] with the objective of reducing the healing time to achieve
secondary stability [4,5]. Furthermore, researchers have also focused, among others aspects, on finding
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the most effective and safest connection between the implant-abutment, the best geometric design [4]
and the most favorable placement of implants in relation to the crestal bone [6].
Despite the effort in research and the advancement in implant design, when an implant is placed,
it is assumed that there will be an unpredictable loss of bone around it, difficult to perfectly forecast
beforehand. In 1986, Albrektsson et al., published a seminal paper, which is still a reference today,
where it is argued that a bone loss of less than 1.5 mm during the first year after implant placement
and less of 0.2 mm annually in the following years, can be considered satisfactory [7].
According to the current literature, the preservation of crestal peri-implant bone is considered a
key feature for the success of the treatment given that the bone around the implant determines the
stability of the soft tissue, which in turn is a crucial aspect for esthetics and long-term survival [8,9].
Within these lines of research, several authors describe that the position in which the implant is
placed with respect to the crestal bone, is a fundamental factor to preserve the bone in the future [10–14].
Although, with respect to this issue there is currently a controversy. Some authors recommend placing
the implant under the crest of the bone (i.e., subcrestal placement). They argue that this specific
position would contribute to the preservation of the mucosa [10], helping to obtain an ideal emergence
profile in esthetic areas [11,12] and would prevent the surface of the implant from being exposed while
reducing the likelihood of suffering from mucositis or peri-implantitis [13]. Along the same lines,
studies with animals pointed out that implants placed at subcrestal level were characterized by less
bone loss with respect to implants placed at the level of the crest [10,14].
By contrast, other authors reported evidences highlighting an increase in bone loss for implants
placed subcrestally [6]. A possible reason for thiscould be attributed to the bacterial colonization of
the implant-abutment junction, where an inflammatory infiltrate is produced [15–17]. This feature,
in concomitance with a low concentration of oxygen, could create an ideal ecosystem for the
proliferation of anaerobic bacteria [18]. Moreover, according to de Siqueira et al. (2017), it could
also be speculated that the deeper placement of the implant may correlate with embolism, deeper
pocketing and inflammation of the soft tissue [12].
Given the controversial results encountered in the literature, the objective of this review is to
systematically evaluate the influence of crestal and subcrestal placement implants with respect to
crestal bone loss and soft tissue and as a result shed more light over this important question.
2. Materials and Methods
The literature considered for this systematic review is based on the PRISMA’ (Preferred Reporting
Items for Systematic Review) [19] guidelines and aims at answering the following specific question
built on the PICO (Population, Intervention, Control, Outcomes) format [20]. For patients treated with
dental implants, are there differences between subcrestal and crestal implants placement with respect
to marginal bone loss?
(P) Population: Patients treated with dental implants.
(I) Intervention: Implant placement at the subcrestal bone level.
(C) Control: Implant placement at the crestal bone level.
(O) Outcome: Bone loss around implants placed at subcrestal and crestal level.
2.1. Inclusion and Exclusion Criteria
Inclusion criteria: recent human clinical studies, comparing bone loss in implants placed with
different vertical positions, at crestal level and subcrestal level. A follow-up period of at least one
month in implants placed in one stage and six months in implants placed in two stages.
Exclusion criteria: articles published in languages other than English. Articles analyzing uniquely
a type of placement (crestal or subcrestal). Articles published before 2010.
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2.2. Search Strategy and Selection of Studies
An electronic search was carried out in PubMed/MEDLINE. The terms used in this search
were: “subcrestal placement and crestal placement implants”, “bone loss in implants placed
crestal-subcrestal”, “subcrestal implants crestal implants”. A manual search was carried out on
the obtained articles, in order to find more articles meeting the inclusion criteria.
Two reviewers (N.P.G. and J.L.L.) assessed independently all titles and abstracts obtained from
the electronic search in order to reach a consensus on the decision to exclude or admit each study.
2.3. Data Extraction
Given the high degree of heterogeneity characterizing the studies included in the review,
a meticulous analysis of the data was carried out in order to compare them. We extracted information
about patients (age, gender, number of implants placed, number of patients treated), characteristics
of the implants and surgical techniques adopted; whether the abutment was placed in a second
procedure (two stages/submerged) versus implants in which the abutment was placed immediately
(one stage/non-submerged); loading of the implants: delayed versus immediate loading; the type of
prosthesis, timing of implant placement (alveolar socket healing versus immediate post extraction);
and follow-up period, the survival rate of the implants and bone loss. Regarding the soft tissue,
different parameters were analyzed: probing pocket depth, bleeding on probing, modified plaque
index, modified gingival index, keratinized tissue, vertical mucosa thickness and histological analysis.
2.4. Methodological Quality of Each Study
Each study was evaluated using the Jadad scale [21], this evaluation method consists of assessing
the methodological quality of the clinical trials. The score goes from 0 to 5, being 0–2 of low quality,
3 of medium quality and 4–5 of high quality.
2.5. Statistical Analysis
Pooled estimates from the studies were analyzed using a continuous random-effects model
meta-analysis. The variable analyzed was crestal bone loss of implants placed at a crestal and at
a subcrestal level. Forest plots were produced to represent graphically the difference in outcomes
of crestal bone loss. p-value = 0.05 was chosen to determine whether differences were statistical
significant. Heterogeneity was assessed with χ2 test and I2 test. R version 3.3.2 (Foundation for
Statistical Computing, Vienna, Austria), and R studio version 1.0.44 Studio, Inc, (Boston, MA, USA)
were employed in the statistical analysis.
3. Results
In the electronic search, a total of 150 articles were identified. Using the keywords “subcrestal
placement and crestal placement implants”, 44 items were found, of which only 11 met the inclusion
criteria. With the keywords “bone loss in implants placed crestal–subcrestal”, 39 items were found,
and only 2 met the inclusion criteria. With “subcrestal implants crestal implants”, 67 studies were
obtained and 0 studies met the inclusion criteria. Three more articles that met the inclusion criteria
were found in a manual search in the literature and were included.
Finally, 16 studies were included in this review for the qualitative synthesis [6,12,22–35]. Nine
were randomized control trials (RCTs) and the other 7 were non-randomized control trials (non-RCT).
For the quantitative synthesis regarding bone loss, 5 RCTs articles were included [6,28,29,32,35]
(Figure 1).
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Figure 1. Flow chart.
3.1. Methodological Quality Assessment
The methodological analysis of Jadad (Table 1) shows that 8 RCT presented a high scientific
quality with scores of 4 and 5, except one of medium quality with a score of 3. Of the 7 non-RCT,
6 were of low quality with scores between 1 and 2 and one of medium quality with a score of 3.
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Table 1. Jadad score in studies selected.
Questions Jadad Q.1 Q.2 Q.3 Q.4 Q.5 Q.6 Q.7 TOTAL
Romanos et al. 2015 [22] 0 1: Implants placed by the same oralsurgeon between 1993 and 2004 −1 1 1 0 0 2
Al Amri et al. 2017 [23] 0
1: Patients having undergone
dental implant therapy for single
missing tooth
−1 1 1 0 0 2
Pellicer et al. 2016 [6] 0 1: Using pre-definedrandomization tables 0 1 1 0 1 4
Palaska et al. 2016 [24] 1 1: Using an online randomizationplan generator 0 1 1 0 1 5
Nagarajan et al. 2015 [25] 0 0 −1 1 1 0‘ 0 1
de Siqueira et al. 2017 [12] 1 1: A computer-generated randomnumber table for patient allocation 0 1 1 0 1 5
Koutouzis et al. 2014 [26] 0
1: A computer-generated list to
distribute the subjects. Treatment
assignments were stored in sealed
envelopes
0 1 1 0 1 4
Koh et al. 2011 [27] 0 1: Assigned by choosing a letterfrom a bag 0 1 1 0 1 4
Vervaeke et al. 2018 [28] 0
1: A systematic non-random
assignment was applied to
determine the position of test and
control implants
0 1 1 0 1 4 *
Kütan et al. 2015 [29] 1 1: Was made by one of the authorsby the flip of a coin 0 1 1 0 1 5
Ercoli et al. 2017 [30] 0
1: Patient had received a dental
implant during a period of 6 years,
from 2009 to 2015
−1 1 1 0 0 2
Veis et al. 2010 [31] 0 0 −1 1 1 0 0 1
Degidi et al. 2011 [33] 0
1: Search in the archives of the
Implant Retrieval Center of the
Dental School of the University of
Chieti-Pescara, Chieti, Italy
−1 1 1 0 1 3
Al Amri et al. 2017 [32] 0 1: Randomization was performedby tossing a coin. 0 1 1 0 1 4
Kim et al. 2017 [34] 0 0 −1 1 1 0 1 2
Fickl et al. 2010 [35] 0 1: All implants placed between 1January and 31 December 2006 −1 1 1 0 1 3
* Vervaeke et al. (2018) should have obtained 3 points as they did not use a random assignment of participants.
Despite that, we decided to give them 4 points as the decision for a non-random procedure was linked to the
sequential nature of their research objective. The Jadad scale of quality of the clinical studies is based in seven
questions. Q. 1: Was the study described as randomized? (Yes: 1 point/No: 0 point); Q. 2: Was the method
of randomization described? (Yes: 1 point/No: 0 point); Q. 3: Was the randomization method appropriate?
(Yes: 0 point/No −1 point); Q. 4: Was the study described as double blind? (Yes: 1 point/No: 0 point); Q. 5:
Was the blinding method described? (Yes: 1 point/No: 0 point); Q. 6: Was the blinding method appropriate?
(Yes: 0 point/No: −1 point); Q. 7: Was there a description of withdrawals and dropouts? (Yes: 1 point/No: 0 point).
A positive point is awarded in the fourth and six question to the articles even if they were single-blind but well
described. In implant placement it is very difficult for the surgeon to proceed if he/she does not know what type of
implant placement he/she is performing. In this case, to score the Jadad point, radiographs should be evaluated by
a person other than the surgeon who placed the implants. The patients were blinded about which implant was the
control or test implant. However, due to the nature of the study, the implant surgeon could not be blinded to the
treatment assignment.
3.2. Characteristics of Studies Included
Of 9 RCTs, 5 did not find significant differences in bone loss [12,24,26,27,32], two articles found a
higher loss of bone in implants placed at the subcrestal level [6,29] and 2 articles found less bone loss
in implants placed at the subcrestal level [28,35].
Of 7 non-RCTs, 5 did not found significant differences between crestal and subcrestal
implants [22,23,25,30,31]. One study found that subcrestal implants presented less bone loss, though
statistical significance was not reached [33] and one study found grater bone loss in subcrestal
implants [34].
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The majority of the studies analyzed uniquely the crestal and subcrestal positions, except for
4 studies that in addition analyzed the supracrestal position [22,30,32,34]. A total of 1346 implants
were placed, of which, 1093 were included in this review and the remaining 253 were excluded
because they were placed in the supracrestal position. Of 1093 implants included, 604 implants were
placed subcrestally, and 489 were placed at the crestal level. Fourteen articles reported the age of
the participants, which ranged from 23 to 82 years, the other two articles did not report it [31,33].
The number of patients treated varied between 9 and 85. Of 16 articles, 10 (62.5%) did not obtain
significant differences between crestal or subcrestal implants in terms of bone loss. For the remaining
6 articles (37.5%), 3 found greater bone loss in implants placed at subcrestal level, while the other
3 remaining articles found the opposite, more bone loss in the implants placed at the crestal level.
Of 1093 implants, 698 were placed in two stages, 302 in one stage and 93 were immediate loading.
The subcrestal implants were installed in a depth ranging from −0.5 mm to −3.4 mm apical to the
alveolar ridge and the crestal implants were placed between 0.0 mm and a maximum of 0.75 mm above
the level of the crestal bone. With respect to the timing of implant placement, in a study with a sample
of 20 implants, all were placed post-extraction [27], 6 studies declared that the implants were placed
on healed edentouls ridges. In 3 studies implants were placed at least 3 months after the healing of the
dental alveolus. In 1 article, implants were placed 6 months after extraction while 6 studies did not
report this information. Of the 16 studies, only 3 performed immediate loading, of these 3, two found
no significant differences [12,26] and one found greater loss in implants placed at the crestal level [33].
Of the 13 studies with delayed loading, 8 did not find significant differences [22–25,27,30–32], 2 found
greater loss in implants placed at crestal level [28,35] and 3 found greater loss in implants placed at
subcrestal level [6,29,34] (Table 2a,b).
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Table 2. Characteristics of studies on randomized control trials (RCT) and non-RCT.
Author StudyDesign
N. of
Patients
Mean Age of
Patients (Years)
N. of
Implants
Surgical
Technique
(One Stage
Two Stages)
Implant
Insertion
Depth below
the Crest
(mm)
Loading of
Implants
Type of
Prosthesis
Timing of
Implant
Placement
Bone Loss in
Subcrestal
Implants (mm)
Bone Loss in
Crestal Implants
(mm)
Follow-up
(Months)
Jadad
Score
Survival
Rate (%)
Outcomes
Related to Bone
Loss between
Two Groups
(a) Characteristics of Studies RCT
Pellicier et al.
2016 [6] RCT
26
15: W
8: M
3: NR
49.8 ± 11.6
23
13: S
10: C
Two stages S: 2.16 ± 0.88C:0.0 Delayed loading
Platform
switching
Crowns screwed
3 months after of
the tooth socket
healing
1.22 ± 1.06 0.06 ± 1.11 12 4 100
Bone loss was
found to be
greater in the
case of the
subcrestal
implants
Palaska et al.
2016 [24] RCT
81
W: 41
M: 40
49
105
54: S
51: C
One stage S: 1.5 ± 0.2C: NR Delayed loading
The implants
were not loaded
After a
minimum of 3
months of
post-extraction
healing
Group 1 (Internal
connection): 0.68
± 0.07
Group 3 (Morse
taper)0.49 ± 0.06
Group 2 (Internal
connection): 0.79
± 0.06
Group 4 (Morse
Taper): 0.40 ± 0.07
3 5 100
No statistically
significant
difference
between
implants with
the same
abutment
connection
pattern
de Siqueira
et al. 2017
[12]
RCT 11 45–65
55
28: S
27: C
Immedia-tely
loading
S: 1–3
C: NR
Immedia-tely
loading an
insertion torque
of at least 45
Ncm
Full-arch
implant fixed
prostheses
NR 1.03 ± 0.60 0.66 ± 0.38 8 5 100 No significantdifferences
Koutouzis et
al. 2014 [26] RCT
30
W: 24
M: 6
49.85
30
20: S
10: C
Immedia-tely
loading
S: −1, −2
C: 0
Immedia-tely
loading
Platform-switched
screw retained
single crowns
Non
post-extraction
submerged 1 mm:
−0.65 ± 0.45
submerged 2 mm:
−0.85 ± 0.75
CBCT analysis
−0.08 ± 0.25 12 4 100
No statistically
significant
differences
between the
groups.
Koh et al.
2011 [27] RCT
24
W: 8
M: 12
(4 patients
group up)
55.5
20
10: S
10: C
Two stages
S: 1 (below the
palatal crest)
C: 0
Delayed loading NR Immediate −0.8 ± 0.6 0.3 ± 0.4 12 4 95.8
No statistically
significant
differences
Vervaeke et
al. 2018 [28] RCT
25
W: 13
M: 12
65 range = 43–82
50
25: S
25: C
Immediate-ly
restored with
locator
abutment One
stage
S: was adapted
to the soft
tissue
thickness,
allowing at
least 3 mm
space for
biologic width
establish-ment
C: NR
Delayed loading
Platform
switching
Overden-ture
Minimum 3
months
post-extraction
0.04 0.73 24 4 100
Subcrestal
implants showed
significantly
better bone
levels
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Table 2. Cont.
Author StudyDesign
N. of
Patients
Mean Age of
Patients (Years)
N. of
Implants
Surgical
Technique
(One Stage
Two Stages)
Implant
Insertion
Depth below
the Crest
(mm)
Loading of
Implants
Type of
Prosthesis
Timing of
Implant
Placement
Bone Loss in
Subcrestal
Implants (mm)
Bone Loss in
Crestal Implants
(mm)
Follow-up
(Months)
Jadad
Score
Survival
Rate (%)
Outcomes
Related to Bone
Loss between
Two Groups
(a) Characteristics of Studies RCT
Kütan et al.
2015 [29] RCT
28
W: 21
M: 7
46.05
56
28: S
28: C
Two stages S: 1C: NR Delayed loading
Platform-switched
cemented
crowns
Minimum 6
months after
extraction
1.21 ± 1.05 0.56 ± 0.35 36 5 100
The mean
radiographic
vertical bone loss
in the crestal
group was
significantly
lower than in the
subcrestal group
Al Amri et al.
2017 [32] RCT
23
W: 7
M: 16
43.5
46
23: S
23: C
One stage S: 2 aproxC: NR Delayed loading
Screw retained
crowns
Healed
edentulous 0.3 ± 0.2 0.45 ± 0.2 36 4 100
No significant
differences in
bone loss around
implants placed
at crestal and
subcrestal levels.
Fickl et al.
2010 [35] RCT
36
W: 18
M: 18
55.3
89
75: S
14: C
Two stages S: NRC: NR Delayed loading Platform-switched
Healed
edentulous
0.30 ± 0.07 at time
of insertion of the
definitive
prosthesis
0.39 ± 0.07 at 1
year
0.68 ± 0.17 at time
of insertion of the
definitive
prosthesis 1.00 ±
0.22 at 1 year
12 3 100
Subcrestal and
platform
switched
implants seem to
limit cretsal bone
remodeling
(b) Characteristics of Studies Non-RCT
Romanos et
al. 2015 [22]
No-RCT
Retrospective
85
M: 41
W: 44
50.51
228
197 mesial
and distal
shoulders: S
65 mesial
and distal
shoulders: C
194 mesial
and distal
shoul-ders
excluded for
being
supra-crestal
Two stages
S: at least
0.5
C: within 0.5
mm or less of
the crestal
bone level)
Supracrestal:
more than 0.5
mm above the
bone level
Delayed loading
Platform-switched
Fixed or
removable
prosthesis
NR Mesial 1.84 (±1.49)Distal 1.73 (±1.31)
Mesial 1.41 (±1.65)
Distal 1.34 (±1.60)
S: 105.61
(±49.74)
C: 94.10
(±52.42)
2 97.8 No significantdifferences
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Table 2. Cont.
Author StudyDesign
N. of
Patients
Mean Age of
Patients (Years)
N. of
Implants
Surgical
Technique
(One Stage
Two Stages)
Implant
Insertion
Depth below
the Crest
(mm)
Loading of
Implants
Type of
Prosthesis
Timing of
Implant
Placement
Bone Loss in
Subcrestal
Implants (mm)
Bone Loss in
Crestal Implants
(mm)
Follow-up
(Months)
Jadad
Score
Survival
Rate (%)
Outcomes
Related to Bone
Loss between
Two Groups
(b) Characteristics of Studies Non-RCT
Al Amri et al.
2017 [23]
No-RCT
Retrospective 52 45.4 ± 1.8
52
27: S
25: C
One stage S: 2 mm aproxC: NR Delayed loading
Single prosthesis.
Platform-switched,
screw retained
metal ceramic
NR 1.2 ± 0.2 1.4 ± 0.2
S: 63.6 ±
2.4
C: 62.4 ±
1.2
2 NR No significantdifferences
Nagarajan et
al. 2015 [25]
No-RCT
Prospective 24
NR
23 to 45
24
12: S
12: C
Two stages S: 1C: NR Delayed loading NR
Healed
edentulous
ridges
0.4917 ± 0.4881 0.2183 ± 0.2874
6 (before
prosthetic
loading)
1 NR
Did not show
difference in
crestal bone loss
before prosthetic
loading.
Was statistically
not significant.
Ercoli et al.
2017 [30]
No-RCT
Retrospective 55 57
134
157 mesial
and distal
shoulders: S
69 mesial
and distal
shoulders: C
42 mesial
and distal
shoulders
excluded for
being
supra-crestal
56.6% Two
stages
43.4% One
stage
NR Delayed loading
71.7% Single
crown
28.3% fixed
dental prosthesis
NR
mesial −1.56 ±
1.11
distal −1.06 ± 0.96
mesial −0.72 ±
1.07
distal −0.91 ± 0.83
18 2 100%
No statistically
significant
differences
Veis et al.
2010 [31]
No-RCT
Retrospective NR NR
282
89: S
95: C
98:
Exclu-ded
for being
supra-crestal
Two stages and
One stage with
short healing
abutments in
the esthetic
zone
S: 1 to 2
C: NR Delayed loading
Cemented an
screw crown and
ridges
Non
post-extraction
Not
platform-switching
0.81 ± 0.79 and
platform switching
0.39 ± 0.52
Not
platform-switching
1.23 ± 0.96 and
platform switching
1.13 ± 0.42
24 1 NR
No statistically
significant
differences.
The platform
switching
concept was
beneficial only in
subcrestal
locations
Materials 2019, 12, 154 10 of 19
Table 2. Cont.
Author StudyDesign
N. of
Patients
Mean Age of
Patients (Years)
N. of
Implants
Surgical
Technique
(One Stage
Two Stages)
Implant
Insertion
Depth below
the Crest
(mm)
Loading of
Implants
Type of
Prosthesis
Timing of
Implant
Placement
Bone Loss in
Subcrestal
Implants (mm)
Bone Loss in
Crestal Implants
(mm)
Follow-up
(Months)
Jadad
Score
Survival
Rate (%)
Outcomes
Related to Bone
Loss between
Two Groups
(b) Characteristics of Studies Non-RCT
Degidi et al.
2011 [33]
No-RCT
Case series 9 NR
9
4: S
5: C
2: Two stages
7:
Immediate-ly
loading
S: 1 to 3
C: NR
2 Delayed
loading
7 Immediately
loading
Platform
switching Single
crown
NR Between 0 and 0.5 Between 0.5 and1.5 1–2 3 100%
In all
subcrestally
placed implants,
preexisting and
newly formed
bone was found
over the implant
shoulder
Kim et al.
2017 [34]
No-RCT
Retrospective 61 51.4
143
286 implant
surfaces
36: S
177: C
73: implant
surfaces
were
excluded for
being
supra-crestal
Two stages
S:NR
C: Within
0–0.75 above
the marginal
bone level
Delayed loading Noplatform-switched
Non
post-extraction 1.76 ± 0.78 1.13 ± 0.91 36 2 NR
In subcrestal
group
signicantly
greater bone loss
was observed at
all time points
from the baseline
RCT: randomized control trial; Non-RCT: not randomized control trial; W: woman; M: men; Y: years; NR: not reported; S: subcrestal implants; C: crestal implants; IL: immediately loading;
N: number.
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The average survival rate was particularly high and equal to 99.4%, representing 629 implants
for the studies reporting it. Four studies, representing 464 implants, did not report the survival
rate [23,25,31,34].
In the RCT studies the follow-up of implants placed varied from 3 to 36 months while in the
non-RCT it ranged from 1 to 155.35 months (Table 2a,b).
3.3. Characteristics of the Implants
Six articles described the type of implants’ surface used [12,22,27,33–35], the rest did not
report it. Regarding the length of the implants, this ranged from 8 to 14 mm and was reported
in 6 studies [6,23,24,28,29,32], the diameters varied from 3.3 to 5 mm and was reported in 8
studies [6,23,24,27–29,32,35] (Table 3).
Table 3. Implant characteristics in studies included.
Study
Commercial Brand Surface Neck and
Diameters and Lengths in Subcrestal
Implants
Commercial Brand, Surface Neck and
Diameters and Lengths in Crestal Implants
Romanos et al. 2015 [22]
Brand implant: ANKYLOS® Implant System,
Mölndal, Sweeden
Type of surface: Sandblasted, acid-etched with
2 mm of machined collar and a progressive
thread design.
Connection: Internal tapered
Lengths: NR
Diameters: NR
Brand implant: ANKYLOS® Implant System,
Mölndal, Sweeden
Type of surface: Sandblasted, acid-etched with
2 mm of machined collar and a progressive
thread design.
Connection: Internal tapered
Lengths: NR
Diameters: NR
Al Amri et al. (RCT) 2017 [32]
Brand implant: Straumann AG, Basel,
Switzerland.
Type of surface: NR
Connection: Internal connection
Lengths: 10 to 14 mm.
Diameters: 3.3 to 4.1 mm
Brand implant: Straumann AG, Basel,
Switzerland.
Type of surface: NR
Connection: Internal connection
Lengths: 10 to 14 mm.
Diameters: 3.3 to 4.1 mm
Pellicer et al. 2016 [6]
Brand implant: Mozo-Grau® Inhex®, S.L.
Valladolid, Spain
Type of surface: NR
Connection: Internal connection Morse tapered
Lengths: 10, 11.5, 13
Diameters: 3.7, 4.2, 5
Brand implant: Mozo-Grau® Inhex®, S.L.
Valladolid, Spain
Type of surface: NR
Connection: Internal connection Morse tapered
Lengths: 10, 11.5, 13
Diameters: 3.7, 4.2, 5
Palaska et al. 2016 [24]
Brand implant: Biomet 3i, Palm Beach
Gardens, FL, USA Certain Prevail nanotite.
Type of surface: NR
Connection: Internal connection
Lengths: 8 to 13 mm
Diameters: 3.5 to 5 mm
Brand implant: OsseoSpeed Astra tech Dental,
Molndal, Sweden
Type of surface: NR
Connection: Morse tapered
Lengths: 8 to 13 mm
Diameters: 3.5 to 5 mm
Nagarajan et al. 2015 [25]
Brand implant: ADINT implants. Adin, Co.
Afula, Israel
Type of surface: NR
Connection: NR
Lengths: NR
Diameters: NR
Brand implant: ADINT implants. Adin, Co.
Afula, Israel
Type of surface: NR
Connection: NR
Lengths: NR
Diameters: NR
de Siqueira et al. 2017 [12]
Brand implant: Titamax CM, Neodent,
Curitiba, PR, Brazil
Type of surface: Sandblasted and acid-etched
Connection: Internal tapered
Lengths: NR
Diameters: NR
Brand implant: Titamax CM, Neodent,
Curitiba, PR, Brazil
Type of surface: Sandblasted and acid-etched
Connection: Internal tapered
Lengths: NR
Diameters: NR
Koutouzis et al. 2014 [26]
Brand implant: Ankylos CX implants
(Dentsply), Mölndal, Sweeden
Type of surface: NR
Connection: Morse taper
Lengths: NR
Diameters: NR
Brand implant: Ankylos CX implants
(Dentsply) Mölndal, Sweeden
Type of surface: NR
Connection: Morse taper
Lengths: NR
Diameters: NR
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Table 3. Cont.
Study
Commercial Brand Surface Neck and
Diameters and Lengths in Subcrestal
Implants
Commercial Brand, Surface Neck and
Diameters and Lengths in Crestal Implants
Koh et al. 2011 [27]
Brand implant: Biohorizons, Birmingham, AL,
USA.
Type of surface: with laser-microtextured collar,
Laser-Lok
Connection: Tapered internal
Lengths: NR
Diameters: 3.8 or 4.6
Brand implant: Biohorizons, Birmingham, AL,
USA.
Type of surface: with laser-microtextured collar,
Laser-Lok
Connection: Tapered internal
Lengths: NR
Diameters: 3.8 or 4.6
Vervaeke et al. 2018 [28]
Brand implant: Astra Tech Osseospeed TX™,
Denstply implants, Salzburg, Austria
Type of surface: NR
Connection: Morse taper
Lengths: 8, 9 or 11 mm
Diameters: 3.5 or 4 mm
Brand implant: Astra Tech Osseospeed TX™,
Denstply implants, Salzburg, Austria
Type of surface: NR
Connection: Morse taper
Lengths: 8, 9 or 11 mm
Diameters: 3.5 or 4 mm
Kütan et al. 2015 [29]
Brand implant: Astra Tech Dentsply Implants,
Mölndal, Sweeden
Type of surface: NR
Connection: Morse taper
Lengths: 9 mm to 13 mm
Diameters: 3.5 or 4 mm
Brand implant: Astra Tech Dentsply Implants,
Astra Tech, Mölndal, Sweeden
Type of surface: NR
Connection: Morse taper
Lengths: 9 mm to 13 mm
Diameters: 3.5 or 4 mm
Ercoli et al. 2017 [30]
Brand implant: NR
Type of surface: NR
Connection: NR
Lengths: NR
Diameters: NR
Brand implant: NR
Type of surface: NR
Connection: NR
Lengths: NR
Diameters: NR
Veis et al. 2010 [31]
Brand implant: full Osseotite implants, Biomet
3i
Type of surface: NR
Connection: Screw-type external-hex titanium
implants
Lengths: NR
Diameters: NR
Brand implant: full Osseotite implants, Biomet
3i
Type of surface: NR
Connection: Screw-type external-hex titanium
implants
Lengths: NR
Diameters: NR
Degidi et al. 2011 [33]
Brand implant: ANKYLOS plus,
DENTSPLY-Friadent, Mannheim, Germany
Type of surface: Acid-etched microtexturized
surface
Connection: Morse tapered
Lengths: NR
Diameters: NR
Brand implant: ANKYLOS plus,
DENTSPLY-Friadent, Mannheim, Germany
Type of surface: Acid-etched microtexturized
surface
Connection: Morse tapered
Lengths: NR
Diameters: NR
Al Amri et al. 2017 [23]
Brand implant: Straumann” Dental Implant
System, Institut Straumann, AG Peter
Merian-Weg 12 CH- 4002 Basel, Switzerland
Type of surface: NR
Connection: Internal connection Regular
crossfit connection implants
Lengths: 10–14 mm
Diameters: 4.1 mm
Brand implant: Straumann” Dental Implant
System, Institut Straumann, AG Peter
Merian-Weg 12 CH- 4002 Basel, Switzerland
Type of surface: NR
Connection: Internal connection Regular
crossfit connection implants
Lengths: 10–14 mm
Diameters: 4.1 mm
Kim et al. 2017 [34]
External connection. Brand implant: Bråemark
System MkIII TiUnite, Nobel Biocare AB,
Göteborg, Sweden
Type of surface: 9 TU:TiUnite
Internal connection Brand implant: OsstemUSII,
Osstem Implant Co., Seoul, Korea
Type of surface: 9 SA: Sand-blasted whit
alumina and acid etching, 9
Brand implant: Pitt-easy FBR, Oraltronics
Dental Implant Technology GmbH, Bremen,
Germany
Type of surface: 18 CP: Calcium phosphate
Connection: Internal and external
Lengths: NR
Diameters: NR
External connection.Brand implant: Brånemark
System MkIII TiUnite, Nobel Biocare AB,
Göteborg, Sweden
Type of surface: 44TU: TiUnite
Internal connection Brand implant: OsstemUSII,
Osstem Implant Co., Seoul, Korea
Type of surface: 53 SA: Sand-blasted whit
alumina and acid etching, 9
Brand implant: Pitt-easy FBR, Oraltronics
Dental Implant Technology GmbH, Bremen,
Germany
Type of surface: 80 CP: Calcium phosphate
Connection: Internal and external
Lengths: NR
Diameters: NR
Fickl et al. 2010 [35]
Brand implant: Osseotite Certain Biomet 3i,
Florida, USA
Type of surface: Dual acid etched
Connection: Internal connection
Lengths: NR
Diameters: 5 mm
Brand implant: Osseotite Certaind Biomet 3i,
Florida, USA
Type of surface: Dual acid etched
Connection: Internal connection
Lengths: NR
Diameters: 4 mm
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With respect to the implants’ connection, in 11 studies implants were characterized by internal
connection [6,12,22–24,26–29,33–35], 8 of them using a Morse taper connection [12,22,24,26–29,33].
Two studies did not report the type of connection used [25,30]. One study used external connection [31]
and one study combined external connection with internal connection both for implants placed at
crestal and subcrestal level [34]. In the rest of the studies, the implants used had the same characteristics.
The implant-related characteristics of studies are reported in Table 3.
3.4. Bone Loss
Among the 16 studies considered, in 10 there were no significant differences between the two
groups with respect to bone loss. In 3 studies, one non-RCT [34] and two RCTs [6,29] with similar
characteristics among them, with the exception of platform-switched that was not used in the non-RCT
study, the bone loss was significantly higher for subcrestal implants. These implants were placed in
two stages, with a follow-up of between 24 and 36 months. In the remaining 3 articles, 2 RCTs [28,35],
and 1 non-RCT [33], the opposite occurred: Fickl et al. (2010) [35] and Vervaeke et al. (2018) [28] with a
follow up of 24 and 12 months respectively, both placed in one stage, subcrestal implants showed better
bone levels than the implants placed at crestal level. In the remaining article, Degidi et al. (2011) [33],
with a follow up of 2 months, the implants placed at subcrestal level found preexisting and newly
formed bone over the implant shoulder.
From the RCT studies, the highest amount of bone loss detected around subcrestal and crestal
implants was exactly the same: 1.22 mm [6] and 1.22 mm [35] respectively.
Ten studies showed an average of bone loss of less than 1 mm in subcrestal implants and 11 studies
a loss of less than 1 mm in crestal implants (Table 2a,b).
3.5. Quantitative Analysis in Bone Loss
A meta-analysis was performed to analyze the mean differences of crestal bone loss between RCT
studies. Of the 9 RCT; five randomized studies [6,28,29,32,35] provided valid data to be included in the
meta-analysis as they evaluated radiologically crestal bone loss of implants placed at crestal (n = 100)
and at subcrestal level (n = 164) with a follow up period between 12 and 18 months. In addition,
the five studies considered used the same type of implant connections (i.e., internal). Two studies
were not included in the meta-analysis because the bone loss evaluation was not carried over with an
intraoral/panoramic radiography. More precisely, a clinical evaluation with a probe was performed on
Koh et al. (2011) [27] and a CBCT analysis was performed on Koutouzis et al. 2016 [26]. Additionally,
the other two studies were not included in the meta-analysis due to the fact that they reported uniquely
a follow-up period up to 8 months [12] and 3 months [24] respectively. The forest plot (Figure 2) shows
a crestal bone loss mean difference of 0.028 mm and a p-value = 0.92 (95% CI (Confidence Interval):
−0.591 to 0.648, heterogeneity I2 = 98.65%, p ≤ 0.001).
The negative values shown in the forest plot represent a higher crestal bone loss for the subcrestal
group. While positive ones represent higher loss of bone for the crestal group.
With respect to the non-RCT studies, a meta-analysis could not be carried out due to the high
level of heterogeneity between the studies included in the review. The main difference comes from the
length of the follow-up periods which varies substantially in five out of seven studies: 1–2 months [33],
63 months [23], 6 months [25], 18 months [30] and 105 months [22]. Only Veis et al. (2010) [31] and
Kim et al. (2017) [34] had comparable follow-up periods of 24 months and 36 months respectively.
Nevertheless, in their case, the connection of the implants varied; being only external in one of the
articles [31] and both external and internal in the other article [34]. Since differences in the connection
may induce a bias in the result, we could not perform a meta-analysis for the non-RCT studies.
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3.6. Soft Tissue
Regarding the soft tissue, in 4 studies no significant differences were found between both vertical
positions [12,23,29,32]. Koh et al. (2011) [27], found better results for the subcrestal implants in terms of
keratinized tissue width, the differ nce being statistically significant. Palaska et al. (2016) [24], found a
significant and highest values in the modified gingival index for th crestal group.
Degidi et al. (2011) [33], were the only ones who performed a histological analysis, the implants
were retrieved from patients two months after their placement. In implants placed at the crestal level,
dense connective tissue was found in the coronal area of the implant, while in subcrestal implants no
gaps or fibrous connective tissue were found at the interface of the implant.
Vervaeke et al. (2018) [28], found a significant correlation between soft tissue thickness and bone
level alterations after 6 months, with higher bone loss for crestal implants when thin tissue was present.
In 8 studies considered in this review, soft tissue was not analyzed (Table 4).
Table 4. Soft tissue.
Author Outcomes Regarding Soft Tissue Analysis in Crestal and Subcrestal Implants
Romanos et al. 2015 [22] Not Analyzed
Al Amri et al. 2017 [23] Probing depth: there was no significant difference in both groupsBleeding on probing: there was no significant difference in both groups
Pellicer et al. 2016 [6] Not Analyzed
Palaska et al. 2016 [24]
Probing depth: was deeper in subcrestal positions but there was no statistically
significant difference between groups (p > 0.05)
Biotype: no statistically significant difference was recorded between groups
Modified plaque index: no statistically significant difference between crestal and
subcrestal implants
Modified gingival index: highest values were recorded for crestal group, being
statistically significant from subcretsal group
Nagarajan et al. 2015 [25] Not Analyzed
de Siqueira et al. 2017 [12]
Keratinized tissue width: no differences in two groups
Vertical mucosa thickness: no differences in two groups
Tissue recession: no differences in two groups
Plaque index bleeding on probing: peri-implant tissues were checked and found
healthy at every follow-up return in the two groups
Koutouzis et al. 2014 [26] Not Analyzed
Koh et al. 2011 [27]
Keratinized tissue width: from baseline to 4 months was 0.7 ± 0.2 mm for the
crestal group and 1.7 ± 0.4 mm for the subcrestal group being statistically
significantly
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Table 4. Cont.
Author Outcomes Regarding Soft Tissue Analysis in Crestal and Subcrestal Implants
Vervaeke et al. 2018 [28]
A significant correlation was observed between soft tissue thickness and bone
level alterations after 6 months with inferior bone levels for crestal implants
when thin tissues are present
Kütan et al. 2015 [29]
Probing depth: no significant differences
Modified plaque index: no significant differences
Modified gingival index: no significant differences
Ercoli et al. 2017 [30] Not Analyzed
Veis et al. 2010 [31] Not Analyzed
Degidi et al. 2011 [33]
Histological analysis
Crestal: dense connective tissue, with only a few inflammatory cells, was
observed at the level of the shoulder of the implant and of the periimplant
coronal portion
Subcrestal: no gaps or fibrous connective tissue was found at the bone-implant
interface.
Al Amri et al. 2017 (RCT) [32] Probing depth: no significant differencesBleeding on probing: no significant differences
Kim et al. 2017 [34] Not Analyzed
4. Discussion
As described in the result section, in 10 studies there were no statistically significant differences
between implants placed at crestal and subcrestal level with respect to bone loss around them. Three
studies found a greater loss in implants placed at the subcrestal level and the 3 remaining studies
found the opposite, a better preservation of the bone in the subcrestal implants. According to the
vast majority of these studies, there is no difference of bone loss between implants placed at crestal
or subcrestal level. Furthermore, as seen in our meta-analysis with a selected homogenous sample,
a crestal bone loss occurs in both cases, and the difference is not statistically significant.
If we take into account that every time we place an implant we expect a loss of bone that can cause
the implant exposure, aesthetic problems and the risk of suffering perimplant pathologies, it seems
natural to think that positioning the implant deeper with respect to the bone crest may be favorable in
order to avoid these potential drawbacks.
In the last few decades, researchers devote substantial effort to shed more light over the causes
responsible for the small loss of bone occurring when an implant is placed especially after the first
months following the placement. As pointed out in the results of this review, the vertical position of
the implant with respect to the bone does not seem to be the main cause of bone loss. This conclusion
is as well in line with the results obtained in Gualini et al. (2017) [36], where no significant differences
regarding bone loss were found for implants placed in different subcrestal positions. Instead, we might
speculate that the loss of bone could differ if we take into account the interaction of more than one
factor simultaneously in addition to the vertical position of the implant such as the platform switching,
the type of connection, the soft tissue characteristics, or the biological width. In the following, we will
analyze the impact of each one of these factors on bone loss with respect to the crestal and subcrestal
placing of the implant.
4.1. Platform-Switching in Relation to the Vertical Position of the Implant
In the concept of platform-switching, the implant/abutment junction moves towards the center of
the implant, with the aim of separating the bacterial filtration from the crestal bone [37]. This type of
design, thanks to the narrowing of the implant/abutment junction may help to minimize the invasion
of the biological width [33].
It is not clear whether platform switching can help to prevent bone loss. Within this review,
6 studies found differences between crestal and subcrestal implants, 5 of them used the concept of
platform-switching and two of them found a greater bone loss in implants placed at the subcrestal
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level [6,29]. This result could possibly be attributed to a deeper implant placement that would be
related to deeper pocketing and inflammation [6]. The other three studies [28,33,35] in contrast,
found less bone loss in subcrestal implants when the platform-switching was used. Several authors
advocate in favor of the platform switching based on the reduced bone loss observed as a result of its
use [31,38,39]. Nevertheless, more research is needed with longer follow-up periods to determine if
platform-switching is more beneficial in terms of reducing bone loss.
4.2. Connection in Relation to the Vertical Position of the Implant
With respect to the implants’ connection, almost the totality of the studies considered in this
review used internal connection and only one study combined internal connection with external
connection between implants placed at crestal and subcrestal level [34]. In this study they found a
higher bone loss in implants placed at the subcrestal level both for internal and for external connections.
This result is in line with a recent systematic review comparing internal and external connection and
pointing out that there are not enough evidences to conclude that one connection is better than the
other with respect to marginal bone loss [40]. Nevertheless, several clinical studies have suggested
that the Morse taper connection with subcrestal implant could be favorable to prevent bone loss, being
most efficient in terms of bacterial sealing and prosthetic stability [33,40].
4.3. Soft Tissue Response to Crestal and Subcrestal Implants
According with the results presented in the study of Verveake et al. (2018) [28], included in this
review, in areas with thin soft tissue, we could anticipate bone remodeling if we adapt the position of
the implant with a more subcrestal placement in relation to the existing soft tissue.
4.4. Biological Width in Relation to the Vertical Position of the Implant
The biological width is present in natural teeth and is composed of the epithelial junction and
connective tissue. Abrahamsson et al., (1996) [41], demonstrated that this space is also formed around
dental implants. According to Oh et al. (2002) [42], the bone remodeling of the crest is influenced
by a variety of factors including the facilitation of the formation of the biological width around the
implant with the objective of creating a barrier against the oral flora. The bone remodeling lasts one
year after placing the implant, being more accentuated at the beginning, and it starts either the same
day of the placement of the implant, if a pillar is placed immediately and the implant is exposed to
the oral environment (one stage), or in a second moment if the pillar is placed later (two stages) [43].
It is for this reason that in our inclusion criteria we decided to accept studies with short follow-up
periods, as long as the implants were placed mostly in one stage. The formation of biological width
around implants could influence the bone remodeling and this fact might explain why the resorption
is more pronounced during the first year, as reported in all the articles included in this review. Of the
studies included in this review, Vervaeke et al. (2018) [28] is the only one that took into account bone
remodeling and biological width, obtaining favorable results. In their study, the thickness of the
soft tissue was measured before placing the implants and a non-random systematic assignment was
applied to determine the position of the subcrestal implant while adapting it to the thickness of the
soft tissue, leaving at least 3 mm of space for the establishment of the biological width. If a patient was
characterized by having 2 mm of the width of the mucosa, they considered placing the implant 1 mm
below the crest in order to anticipate bone remodeling and avoid future exposure of the implant.
As suggested by Kan et al. (2010) [44], the gingival biotype can be considered thin if the
measurement is ≤1.0 mm and thick if it measures >1.0 mm. Several studies reported an increase in
bone loss in implants placed at the crestal level with thin biotypes and have concluded that a minimum
amount of keratinized tissue is needed around the implants to reduce tissue recession [45,46] and
crestal bone loss [28,42,47–49].
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5. Conclusions
The existing literature is not yet conclusive on whether one of these positions of implant placement
is superior to the other. In this review we observed that in the vast majority of articles there are no
differences and that the loss of bone that always occurs when an implant is placed, is not due strictly to
the location of the implant with respect to the bone, as it continues to occur in both vertical positions.
Moreover, appropriate clinical results with a high survival rate and a similar bone loss were
obtained both for crestal and subcrestal implants’ placement.
Although, with respect to soft tissue, in presence of a thin tissue, a subcrestal placement of the
implant should be preferred as it may reduce the probability for the implant to get exposed in the
future and thus, avoiding the risk of suffering from peri-implant pathologies. Nevertheless, to fully
support this statement, more precisely designed and more homogenous clinical trials with larger
samples and longer follow-up periods are needed.
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